Sangamo Therapeutics, Inc. · NASDAQ:SGMO
Wasatch Advisors LP reported a 5.20% stake in Sangamo Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 12, 2025
Wasatch Advisors LP reported a 5.20% stake in Sangamo Therapeutics, Inc., 11,630,671 shares, as a passive investor on Mar 31, 2025. Filed May 12, 2025 (Schedule 13G/A).
- Stake
- 5.20%
- Shares
- 11,630,671
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| WASATCH ADVISORS LP | 5.20% | 11,630,671 |
Source
Related
- Sangamo Therapeutics, Inc.
- Wasatch Advisors LP
- Sangamo Therapeutics, Inc. shareholders
- Schedule 13G/A · Wasatch Advisors LP · Nov 12, 2025
- Schedule 13G/A · Wasatch Advisors LP · Jan 7, 2025
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Form 4 · Davis Gregory D · May 27, 2026
- Form 4 · Jain Nikunj · May 27, 2026
- Form 4 · Dubois-Stringfellow Nathalie · May 27, 2026
- Form 4 · Willoughby Scott B. · May 27, 2026